Our teams: METHODS

I am an Associate Professor in the Immunology and Infectious Diseases Department at the Hotel-Dieu Hospital, University of Paris Cité and a member of the METHODS team of CRESS-UMR1153.

As a physician involved since the beginning of the HIV pandemic, I have always combined my clinical activity with clinical research in the field of HIV infection and its complications. I was involved in several clinical trials from phase I to IV as well as observational studies and cohorts.

I have worked as an associate Professor at Northwestern University, Feinberg School of Medicine, Chicago, Illinois with the Multicenter AIDS Cohort Study (MACS), which is an ongoing prospective study of HIV-1 infection among men who have sex with men (MSM) at four centers in the United States: Chicago, Baltimore/Washington DC, Pittsburgh and Los Angeles. I also became a member of the Metabolic Working group, MWCCS, NIH, Bethesda, Washington.

I am also in the editorial board for AIDS

Research interests

  • Physiopathology of HIV infection and the impact of its treatment
  • Metabolic disorders in HIV
  • Risk factors in the genesis of HIV complications

Key publications

  • Slama L, Lanoy E, Valantin MA, Bastard JP, Chermak A, Boutekatjirt A, William-Faltaos D, Billaud E, Molina JM, Capeau J, Costagliola D, Rozenbaum W. Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113) in Antivir. Ther. 2008; 13(1):67-76.
  • Slama L, Li X, Brown TT, Jacobson LP, Pialoux G, Macatangay B, Bolan R, Phair J, and Palella FJ for the Multicenter AIDS cohort Study (MACS). Increases in Duration of First HAART over Time (1996-2009) and Associated Factors in the Multicenter AIDS Cohort Study in J Acquir Immune Defic Syndr. 2014; 65(1): 57-64*.
  • Slama L, Barrett BW, Abraham AG, Palella FJ, Kingsley L, Viard JP, Lake JE, Brown TT. Risk for incident diabetes is greater in pre-diabetic men with HIV than without HIV in AIDS 2021; 35(10):1605-1614*.
  • Supervie V, Assoumou L, Breban R, Lert F, Costagliola D, Pialoux G, Landman R, Girard PM, Slama L; IMEA 040 DATA Study Group. Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression in J Antimicrob Chemother. 2017; 72(11):3172-3176.
  • Kousignian I, Sautereau A, Vigouroux C, Cros A, Kretz S, Viard JP, Slama L Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: a real-life setting study in PLoS One 2021: 16(5):e0250676*.

Back to top